PXRB Stock - PixarBio Corporation
Unlock GoAI Insights for PXRB
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
PixarBio Corporation, a specialty pharmaceutical/biotechnology company, focuses on the pre-clinical and clinical development of neurological drug delivery systems for post-operative pain. The company researches and develops delivery systems for drugs, devices, or biologics to treat pain, epilepsy, epilepsy, Parkinson's disease, and spinal cord injury. Its principal product platform is NeuroRelease for the therapeutic release of non-opiate drugs for post-operative, acute, and chronic pain in pre-clinical models. The company was founded in 2014 and is based in Medford, Massachusetts.
Earnings History & Surprises
PXRBLatest News
Frequently Asked Questions about PXRB
What is PXRB's current stock price?
What is the analyst price target for PXRB?
What sector is PixarBio Corporation in?
What is PXRB's market cap?
Does PXRB pay dividends?
Similar Stocks
Consumer Cyclical SectorExplore stocks similar to PXRB for comparison